Etiologies of Long-Term Postcholecystectomy Symptoms: A Systematic Review by Latenstein, C.S.S. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/205158
 
 
 
Please be advised that this information was generated on 2019-08-14 and may be subject to
change.
Review Article
Etiologies of Long-Term Postcholecystectomy Symptoms:
A Systematic Review
Carmen S. S. Latenstein,1 Sarah Z. Wennmacker,1 Judith J. de Jong,2
Cornelis J. H. M. van Laarhoven,1 Joost P. H. Drenth,2 and Philip R. de Reuver 1
1Department of Surgery, Radboud University Medical Centre, Nijmegen, Netherlands
2Department of Gastroenterology, Radboud University Medical Centre, Nijmegen, Netherlands
Correspondence should be addressed to Philip R. de Reuver; philip.dereuver@radboudumc.nl
Received 9 November 2018; Revised 28 January 2019; Accepted 10 February 2019; Published 14 April 2019
Academic Editor: Konstantinos Triantafyllou
Copyright © 2019 Carmen S. S. Latenstein et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Background. Cholecystectomy does not relieve abdominal symptoms in up to 40% of patients. With 700,000 cholecystectomies
performed in the US, annually, about 280,000 patients are left with symptoms, making this a serious problem. We performed a
systematic review to determine the diﬀerent etiologies of long-term postcholecystectomy symptoms with the aim to provide
guidance for clinicians treating these patients. Methods. A systematic search of the literature was performed using MEDLINE,
EMBASE, and Web of Science. Articles describing at least one possible etiology of long-term symptoms after a laparoscopic
cholecystectomy were included in this review. Long-term symptoms were deﬁned as abdominal symptoms that were present at
least four weeks after cholecystectomy, either persistent or incident. The etiologies of persistent and incident symptoms after LC
and the mechanism or hypothesis behind the etiologies are provided. If available, the prevalence of the discussed etiology is
provided. Results. The search strategy identiﬁed 3320 articles of which 130 articles were included. Etiologies for persistent
symptoms were residual and newly formed gallstones (41 studies, prevalence ranged from 0.2 to 23%), coexistent diseases
(64 studies, prevalence 1-65%), and psychological distress (13 studies, no prevalence provided). Etiologies for incident
symptoms were surgical complications (21 studies, prevalence 1-3%) and physiological changes (39 studies, prevalence 16-58%).
Sphincter of Oddi dysfunction (SOD) was reported as an etiology for both persistent and incident symptoms (21 studies,
prevalence 3-40%). Conclusion. Long-term postcholecystectomy symptoms vary amongst patients, arise from diﬀerent etiologies,
and require speciﬁc diagnostic and treatment strategies. Most symptoms after cholecystectomy seem to be caused by coexistent
diseases and physiological changes due to cholecystectomy. The outcome of this research is summarized in a decision tree to
give clinical guidance on the treatment of patients with symptoms after cholecystectomy.
1. Introduction
In the United States (US), approximately 1.8 million patients
are diagnosed with gallstones every year [1]. In the majority
of patients, gallstones will stay asymptomatic. Approximately
20% of patients will experience symptoms, like a biliary colic,
for which laparoscopic cholecystectomy (LC) is the preferred
treatment [2–4]. As a consequence, LC is one of the most
performed elective abdominal surgeries worldwide, with
approximately 700,000 LCs in the US [5].
Although LC is the preferred treatment to relieve
symptoms, previous studies show that long-term abdomi-
nal symptoms are present in up to 40% of patients after
LC [6–9]. This equals a yearly growth of 280,000 cases
with abdominal symptoms after LC in the US. Patients
suﬀer from symptoms like diarrhea, gas bloating, nausea,
vomiting, jaundice, or abdominal pain. These symptoms
after LC are a signiﬁcant burden to health care systems,
as 56% of patients need additional health care for diagnosis
and treatment, against direct median hospital costs of $555
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per year per patient. Moreover, sick leave and production loss
of employed patients add an additional $361 per year per
patient for work-related costs [10].
Abdominal symptoms after LC are often summarized as
“postcholecystectomy syndrome.” However, postcholecys-
tectomy syndrome is an arbitrary term that loosely describes
the presence of symptoms after LC and consists of many
persistent and incident symptoms [11–15]. In order to help
patients with abdominal symptoms after LC, a speciﬁc
diagnosis or etiology of the complaints is needed to provide
targeted treatment. Therefore, this systematic review is aimed
at providing an overview of the literature on etiologies of
abdominal symptoms after LC and ultimately to assist
clinicians in identifying the cause of patients’ symptoms after
LC and optimize treatment.
2. Methods
The PRISMA guideline (Preferred Reporting Items for
Systematic Reviews and Meta-Analyses) was used to perform
this systematic review [16].
2.1. Search Strategy. A systematic literature search was con-
ducted in the electronic databases of MEDLINE (1946–
June 2018), Web of Science (1945–June 2018), and
EMBASE (1980–June 2018). The search was performed
using a search strategy that included terms for “(postcho-
lecystectomy) abdominal symptoms,” “cholecystectomy,”
and “cholecystolithiasis” (the full search strategy is shown
in Supplementary Table 1).
2.2. Study Selection. Two reviewers (C.L. and S.W.) indepen-
dently screened the titles and abstracts of the identiﬁed arti-
cles to select potentially relevant studies. Studies on
abdominal symptoms after LC in uncomplicated cholecysto-
lithiasis patients ≥ 18 years, reporting at least one potential
etiology for long-term symptoms, were eligible for inclusion.
Long-term symptoms after LC were deﬁned as any type of
abdominal symptoms that were present at least four weeks
after LC. Case reports, case series, editorials, and studies in
a language other than English, Dutch, or German were
excluded. Studies including patients after open cholecystec-
tomy were excluded, as this does not reﬂect current surgi-
cal practice [17]. Discrepancies between the reviewers were
resolved by discussion and consensus. In case of overlap-
ping data, the most recent study with the largest cohort
was included.
2.3. Data Extraction and Synthesis. Data were independently
extracted by the two reviewers (C.L. and S.W.), using a prede-
ﬁned data extraction form. All described etiologies for long-
term postcholecystectomy symptoms and the prevalence of
these etiologies (if provided in the study) were extracted. Fur-
ther extracted data included the following study characteris-
tics: author, year of publication, country, study design,
sample size, and follow-up period, and additional data on
patients’ age and gender, and long-term postcholecystectomy
symptoms. Again, discrepancies between reviewers were
resolved by discussion and consensus.
Subsequently, all etiologies were categorized as etiology
for “persistent symptoms” or “incident symptoms” after LC
and reported in subgroups per category. Persistent symptoms
were deﬁned as symptoms that are similar to patients’ preop-
erative symptoms. Incident symptoms were deﬁned as symp-
toms that were not present before LC. Primary outcomes of
this review were the etiologies of persistent and incident
symptoms after LC; the range in prevalence of each etiology
in the included studies was reported.
3. Results
3.1. Selected Studies. The search strategy identiﬁed 3320
articles. After removal of duplicates, titles and abstracts
of 2226 articles were screened and 269 articles were
selected for full-text evaluation. Finally, 130 articles were
included in this review, as shown in Figure 1.
3.2. Study Characteristics. The included studies composed of
77 prospective cohort studies, 24 retrospective cohort studies,
20 reviews, ﬁve randomized controlled trials, and four sys-
tematic reviews. Most studies were performed in Europe
and North America. The postoperative follow-up period in
the included studies varied from four weeks to 18 years after
LC. Full study characteristics are summarized in Table S2 in
the supplementary ﬁles.
3.3. Reported Etiologies of Long-Term Symptoms after LC.
The reviewed literature reported the following symptoms:
biliary pain, pain attacks, continuous pain, pain related to
food, functional dyspepsia, nausea, vomiting, abdominal
bloating, reﬂux, diarrhea, constipation, functional bowel
problems, fever, and jaundice.
Persistent symptoms after LC were summarized into four
subgroups: “residual and newly formed gallstones,” “coexis-
tent diseases,” “psychological distress,” and “sphincter of
Oddi dysfunction.” Three subgroups for etiologies of inci-
dent symptoms after LC were established: “sphincter of Oddi
dysfunction,” “surgical complications,” and “physiological
changes” (Figure 2). Sphincter of Oddi dysfunction (SOD)
can cause persistent symptoms; however, most often it arises
after LC. The etiologies reported per included study and if
provided the percentage of patients with a certain etiology
as cause for symptoms after LC are summarized in Table S2.
4. Persistent Symptoms
4.1. Residual and Newly Formed Gallstones. Forty-one studies
reported residual or newly formed gallstones as the etiology
for long-term persistent abdominal symptoms after LC. A
total of 23 studies provided the prevalence of residual and
newly formed gallstones as the cause for symptoms, ranging
from 0.2% to 23%. Residual stones are most commonly diag-
nosed as retained common bile duct stones (choledocholithi-
asis), stones, or sludge in a cystic duct remnant or stones
within the remnant gallbladder due to a subtotal cholecystec-
tomy in diﬃcult surgical cases. Residual stones in the cystic
duct or gallbladder remnant can result in recurrent biliary
colics [18–22]. Usually, these symptoms are self-limiting.
Choledocholithiasis after LC is associated with epigastric
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pain, elevated ALT and AST levels, and sometimes jaundice
[22–24]. Additional abdominal ultrasound might show a
dilated common bile duct [19]. Moreover, new gallstones
can be formed within the bile ducts or gallbladder remnants,
after LC. Depending on the location in the biliary tract,
symptoms will be similar to cystic duct or gallbladder rem-
nant stones, or choledocholithiasis [25, 26].
4.2. Coexistent Diseases. Sixty-four studies reported coexis-
tent diseases as the etiology for long-term persistent abdom-
inal symptoms after LC. Eighteen studies provided the
prevalence of coexistent diseases after LC ranging from 1%
to 65%. Coexistent diseases in patients with gallstones are
common and mainly nonbiliary: gastroesophageal reﬂux,
peptic ulcer, hiatus hernia, gastritis, constipation, IBS, Ante-
rior Cutaneous Nerve Entrapment Syndrome (ACNES), fatty
liver disease, chronic obstructive pulmonary disease, or coro-
nary artery disease [27, 28]. Preoperative distinction between
symptoms caused by coexistent diseases and gallstones is
challenging [29–32]. Misinterpretation of symptoms and
suboptimal indication for LC will result in persistent symp-
toms after surgery [8, 9, 27, 30–36]. Even if the indication
for LC was made correctly and the biliary symptoms are
resolved, symptoms of a coexistent disease can become
more prominent and considered as persistent symptoms
after LC [29, 37].
4.3. Psychological Distress. Thirteen studies reported psycho-
logical distress as the etiology for long-term persistent
abdominal symptoms after LC. None of these studies pro-
vided prevalence for psychological distress as cause for
symptoms after LC. Several hypotheses exist on why
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psychologically distressed patients are more likely to expe-
rience persistent symptoms after LC. First, psychologically
distressed patients tend to experience more functional
gastrointestinal symptoms, which are not relieved by LC
[38–40]. Secondly, psychological distress may induce vis-
ceral hyperalgesia that exacerbates subjective perception
of pain both preoperatively and postoperatively [41].
Third, these patients are prone to experience somatization
symptoms which may cause overreporting of symptoms
[42]. Somatization symptoms are also less likely to be alle-
viated by surgery [39, 43]. Considering the diﬀerent per-
ceptions and interpretations, patients with psychological
distress are more at risk for poor decision-making [38–40].
4.4. Sphincter of Oddi Dysfunction. Seventeen studies
reported sphincter of Oddi dysfunction (SOD) as the etiology
for long-term abdominal symptoms after LC. Prevalence of
SOD after LC was reported in four studies and ranged from
3% to 40%. SOD mainly presents as right upper quadrant
(biliary) pain and is not easily distinguished from symp-
tomatic cholecystolithiasis, irritable bowel syndrome, or
functional dyspepsia [44]. If SOD symptoms have been
incorrectly attributed to gallstones, symptoms will persist
after LC [15, 45, 46]. However, SOD most often com-
mences after LC as incident symptoms, in which case
interrupted neural pathways between the duodenum, gall-
bladder, and sphincter of Oddi after surgery lead to
sphincter of Oddi spasms or SOD [47–50]. SOD can be
divided in three types: type I (biliary pain, abnormal liver
tests, and dilated bile duct), type II (biliary pain and
abnormal liver tests or dilated bile duct), and type III
(only biliary pain) [51, 52].
5. Incident Symptoms
5.1. Surgical Complications. Twenty-one studies reported
surgical complications as the etiology for long-term symp-
toms after LC. Prevalence of long-term symptoms after LC
caused by surgical complications was reported in eight stud-
ies, ranging from 1% to 3%. Bile duct injury is the most feared
surgical complication [53, 54]. Patients can develop upper
abdominal pain with jaundice, fever, and possibly sepsis
[48]. Even if the bile duct injury is treated with surgical
or endoscopic intervention, strictures or leakages can
result in long-term symptoms of pain and biliary obstruc-
tion [15, 53, 55].
Spillage of gallstones into the peritoneal cavity is another
complication associated with long-term postoperative pain,
which can lead to abscesses, general peritonitis, adhesions,
and ﬁstulae, even several years after surgery [56–59]. How-
ever, the majority of dropped gallstones remain clinically
silent [58].
Pain or discomfort due to late postoperative complica-
tions can arise from infections, wound healing problems, or
a trocar site hernia [40, 60–67].
5.2. Physiological Changes. Thirty-nine studies reported
physiological changes after surgery as the etiology for
incident abdominal symptoms after LC. The prevalence
of physiological changes after LC was described in 17
studies, ranging from 16% to 58%. Long-term eﬀects
of LC on bile acid metabolism were reported in several
studies [61, 68–70]. Prior to LC, bile acids are stored in
the gallbladder and bile acids are released in the duodenum
by meal-induced intermittent contractions. LC results in
the loss of reservoir function of the gallbladder and an altered
bile metabolism. The pathophysiology of increased bile ﬂow
has not been completely clariﬁed. However, the continuous
ﬂow of bile acids into the duodenum attributes to increased
duodenal-gastric reﬂux and can cause symptoms of dyspep-
sia and an elevated risk of gastritis [49, 71–73]. Decreased
esophageal sphincter pressure after LC may further attribute
to dyspepsia and gastritis symptoms [61, 66, 74].
The reduced bile salt pool after LC could also induce
subclinical fat malabsorption and result in diarrhea. The con-
stant presence of bile acids in the gut, which promotes secre-
tion and motility, could additionally result in a shortened
whole gut transit time, contributing to postoperative diarrhea
and ﬂatulence [49, 68, 69].
5.3. Others. Fifteen studies reported various other etiologies
for incident long-term abdominal symptoms after LC. Chan-
ged dietary intake, mainly waiving preoperative dietary
restrictions, or physical inactivity may attribute to symptoms
after LC [61, 75].
6. Discussion
This systematic review provides a qualitative overview of eti-
ologies of long-term abdominal symptoms after LC. Most
symptoms after LC seem to be caused by coexistent diseases
and physiological changes due to LC. Based on the etiologies
of persistent and incident symptoms after LC provided in this
review, we constructed a decision tree to help clinicians iden-
tify the cause of long-term symptoms after LC and optimize
treatment for these patients (Figure 3).
“Postcholecystectomy syndrome” is a collective term for
all symptoms after LC. This general term is not an adequate
diagnosis [76–78], as multiple etiologies requiring distinct
treatments may cause “postcholecystectomy syndrome.”
Moreover, some symptoms are not even related to LC itself.
To establish the cause of long-term symptoms after LC and
decide on the proper treatment to alleviate symptoms, the
underlying etiology of symptoms should be pursued.
Previous reviews divided all causes for symptoms after
LC into organ systems [13] (e.g., biliary causes, pancreatic
causes, other gastrointestinal disorders, or extraintestinal dis-
orders) or listed all diagnoses individually (e.g., peptic ulcer
disease, hiatus hernia, gastroesophageal reﬂux, residual
stones, strictures, and SOD) [76]. The latter is a review with
a limited search reach and only 21 included articles [76]. In
this review, we categorized long-term postoperative symp-
toms as persistent or incident symptoms after LC, thereby
providing a ﬁrst step in deducting the causes for long-term
symptoms. If the persistent or incident nature of the symp-
toms is established, the categories and subgroups presented
in this review are a tool for clinicians in the assessment of
long-term postcholecystectomy symptoms (Figure 3).
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We established that most persisting symptoms are likely
to be caused by coexisting diseases; often, these will be non-
biliary symptoms. Detailed anamnesis and tailored diagnos-
tic tests (such as ultrasound, gastroscopy, and colonoscopy)
will provide insight in the presence of (functional) abdominal
disorders. Accessible therapeutic options should conﬁrm or
rule out the diagnosis, for instance, with a test treatment with
antacids or laxatives [26, 32, 35, 36, 79].
Persisting biliary pain will mainly be caused by newly
formed or residual stones or SOD. These conditions can
be diagnosed using abdominal or endoscopic ultrasound.
Gallstones will most often be present in the CBD and
can be treated by ERCP with papillotomy and stone
extraction. SOD type I and II can be distinguished from
other disorders by laboratory results, imaging of the bili-
ary tree, and elevated sphincter pressure at manometry.
SOD type III is diﬃcult to distinguish from other gastro-
intestinal disorders, as the only criterion is biliary pain.
Some literature recommends endoscopic sphincterotomy
to treat SOD [15, 45]; however, recently published long-
term results of the EPISOD study show that in type III
SOD, endoscopic sphincterotomy was not more successful
compared to sham intervention in patients with
postcholecystectomy SOD type III [80, 81]. Another study
recommends medical treatment, trimebutine, and nitrates
taken sublingually, as success rates are similar with endo-
scopic sphincterotomy [82].
Newly formed symptoms will often start shortly after LC
but can persist and become a long-term problem. Patients
with surgical complications should therefore be monitored
at the outpatient clinic to obviate persisting symptoms, and
surgical, endoscopic, or medical treatment can be started
timely (e.g., surgical or endoscopic intervention with a stent
or dilatation for bile duct injury or antibiotics for (intra-
abdominal) infections). Most incident symptoms will how-
ever be physiological. Patients with new reﬂux symptoms
after LC (due to physiological changes in bile secretion and
metabolism) can be pragmatically treated with lifestyle
changes, drugs that reduce the secretion of gastric acids, pro-
kinetic drugs, or drugs that reduce the relaxations of the
esophageal sphincter, to reduce reﬂux and relieve symptoms.
Patients with (invalidating) chronic diarrhea can be treated
with a bile acid sequestrant like cholestyramine, colestipol,
or colesevelam [83].
Although this study provides tools to establish and treat
symptoms, of course, preventing postoperative symptoms is
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preferable. A prospective study showed that 56% of patients
need additional health care and medical costs and costs for
sick leave were approximately $916 per year per patients
[10]. Improved patient selection and preoperative work-
up for a LC could prevent persistent abdominal symptoms
and costs.
In patients with nonspeciﬁc gallstone symptoms, the pre-
operative diagnostic trajectory should focus on conﬁrming or
ruling out other causes of upper abdominal symptoms and
considering alternative or concomitant therapeutic options.
Our research group is currently performing a multicenter
prospective study (Dutch Trial Register: NTR7307) to
identify the prevalence of functional gastrointestinal disor-
ders (FGID) in patients with gallstones. Current literature
suggests prevalence of up to 60% [26, 39, 84, 85]. If such
high prevalence is accurate, a large part of persistent
symptoms after LC could be explained by coexistent FGID
and treatment to prevent persistent symptoms could be
initiated prior to surgery. A second prospective study
(NTR7267) focuses on establishing the abdominal symp-
toms for appropriate indication of LC to prevent persistent
symptoms caused by wrong surgical indication.
Additionally, shared decision-making and increased
inﬂuence in choosing their preferred treatment may result
in improved physical outcomes and less distress. This is
illustrated for psychologically distressed patients [42] but
may very well apply for other patients. Furthermore, we
should consider that symptoms before and after LC may
be present as part of the metabolic syndrome [86–88].
The metabolic syndrome is described as the underlying
disorder for gallstones by abnormalities of insulin resis-
tance, resulting in increased biliary cholesterol synthesis
and gallstone formation [86]. LC is aimed at treating the
gallstone symptoms, but the lifestyle and other comorbid-
ities associated with the metabolic problem remain
untreated. Incorporation of lifestyle changes and treatment
of other aspects of the metabolic syndrome could reduce
postoperative symptoms in this patient category.
The present review comes with strengths and limita-
tions. Strengthening our study are the broad search and
wide inclusion criteria to identify all possible etiologies of
long-term abdominal symptoms after LC. Articles on open
cholecystectomy were excluded, to prevent bias by etiolo-
gies or prevalence (such as higher surgical complications)
inherent to the open aspects of the surgery, not reﬂecting
current surgical practice. Additionally, diﬀerentiation
between incident and persistent symptoms and descrip-
tions of subgroups of etiologies were made to improve
clinical applicability of the results. Ultimately, a clinical
guidance was provided for physicians in the diagnostics
and treatments of patients with symptoms after LC.
Limitations include the large heterogeneity of the
included studies and subsequent inability to perform a
quality assessment. As only a limited number of included
studies reported the prevalence of described etiologies, we
could not provide a meta-analysis. Subsequently, we were
only able to provide the range of prevalence of the diﬀer-
ent etiologies to illustrate which etiologies are more and
less common.
7. Conclusion
Postcholecystectomy symptoms have multiple etiologies and
can be divided into persistent and incident symptoms. Most
symptoms seem to be caused by coexistent diseases and phys-
iological changes due to LC. Although treatment is available
for most causes of persistent symptoms after gallbladder
removal, optimized indication for surgery remains key.
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